Published in Immunology on October 01, 1996
The nitric oxide pathway provides innate antiviral protection in conjunction with the type I interferon pathway in fibroblasts. PLoS One (2012) 0.83
Dimerization of major histocompatibility complex class I on the surface of THP-1 cells stimulates the expression of inducible nitric oxide synthase and subsequent nitric oxide release. Immunology (2000) 0.75
Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev (1991) 42.38
Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science (1994) 26.02
Macrophage oxidation of L-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry (1988) 10.17
Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med (1989) 7.72
Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. J Biol Chem (1994) 6.91
Functional macrophage cell lines transformed by Abelson leukemia virus. Cell (1978) 5.76
Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J Biol Chem (1992) 4.88
Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. Proc Natl Acad Sci U S A (1993) 4.73
Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science (1994) 4.50
Identification of macrophage-like characteristics in a cultured murine tumor line. J Immunol (1975) 4.10
Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Med (1993) 4.06
Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol (1988) 4.04
Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J Exp Med (1984) 4.00
Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med (1993) 3.06
Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing. Molecular basis for the synergy between interferon-gamma and lipopolysaccharide. J Biol Chem (1993) 2.96
Synthesis of nitrite and nitrate in murine macrophage cell lines. Cancer Res (1987) 2.69
Recognition DNA sequences of interferon regulatory factor 1 (IRF-1) and IRF-2, regulators of cell growth and the interferon system. Mol Cell Biol (1993) 2.51
Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med (1994) 2.35
Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am Rev Respir Dis (1990) 1.90
Dual mechanism for the control of inducible-type NO synthase gene expression in macrophages during activation by interferon-gamma and bacterial lipopolysaccharide. Transcriptional and post-transcriptional regulation. J Biol Chem (1994) 1.35
Human monocytes are stimulated for nitric oxide release in vitro by some tumor cells but not by cytokines and lipopolysaccharide. Eur J Immunol (1994) 1.30
Interferon gamma regulates binding of two nuclear protein complexes in a macrophage cell line. Proc Natl Acad Sci U S A (1990) 1.21
Nitric oxide production by human monocytes: evidence for a role of CD23. Immunol Today (1995) 1.20
The C-terminus of IFN gamma is sufficient for intracellular function. Biochem Biophys Res Commun (1994) 1.04
Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. J Immunol (1986) 0.95
Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages. Eur J Immunol (1988) 4.04
Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest (1986) 2.76
L-arginine-dependent destruction of intrahepatic malaria parasites in response to tumor necrosis factor and/or interleukin 6 stimulation. Eur J Immunol (1991) 1.95
Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J (1993) 1.83
Regulation of human gamma-interferon and beta-interferon gene expression in PHA-activated lymphocytes. J Interferon Res (1986) 1.81
Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry (1974) 1.79
IFN-gamma-activated macrophages: detection by electron paramagnetic resonance of complexes between L-arginine-derived nitric oxide and non-heme iron proteins. Biochem Biophys Res Commun (1990) 1.60
Synergistic protection by specific antibodies and interferon against infection by Trypanosoma cruzi in vitro. Eur J Immunol (1984) 1.58
Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations? Acta Neurol Scand (1988) 1.57
Cell walls of Mycobacteria and related organisms; chemistry and immunostimulant properties. Mol Cell Biochem (1975) 1.55
EPR characterization of molecular targets for NO in mammalian cells and organelles. FASEB J (1993) 1.54
Physico-chemical characterization and partial purification of mouse immune interferon. J Gen Virol (1979) 1.49
Expression of Ia antigens by cultured astrocytes treated with gamma-interferon. Neurosci Lett (1983) 1.48
Intermittent hemophagocytic lymphohistiocytosis is a regular feature of lysinuric protein intolerance. J Pediatr (1999) 1.44
Yeast tRNALeu (anticodon U--A--G) translates all six leucine codons in extracts from interferon treated cells. FEBS Lett (1977) 1.41
Enhancement of nonspecific immunity to bacterial infection by cord factor (6,6'-trehalose dimycolate). J Infect Dis (1977) 1.40
Interleukin-4 stimulates cGMP production by IFN-gamma-activated human monocytes. Involvement of the nitric oxide synthase pathway. J Biol Chem (1994) 1.29
Nitric oxide, a biological effector. Electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur Biophys J (1991) 1.27
Two cis-DNA elements involved in myeloid-cell-specific expression and gamma interferon (IFN-gamma) activation of the human high-affinity Fc gamma receptor gene: a novel IFN regulatory mechanism. Mol Cell Biol (1993) 1.17
IFN-beta induces serine phosphorylation of Stat-1 in Ewing's sarcoma cells and mediates apoptosis via induction of IRF-1 and activation of caspase-7. Oncogene (2000) 1.14
IL-6 and IL-6 receptor modulation by IFN-gamma and tumor necrosis factor-alpha in human monocytic cell line (THP-1). Priming effect of IFN-gamma. J Immunol (1991) 1.12
Differential susceptibility to acute Trypanosoma cruzi infection in BALB/c and C57BL/6 mice is not associated with a distinct parasite load but cytokine abnormalities. Clin Exp Immunol (2002) 1.08
Delineation of three subsets of class I human T antigens (HTA) on Molt-4 cells: serologic and regulatory relationship to HLA class I antigens. J Immunol (1985) 1.07
Structural study of the poly-l-Glutamic acid of the cell wall of Mycobacterium tuberculosis var hominis, strain Brevannes. Biochem Biophys Res Commun (1975) 1.06
Involvement of the transcription factor PU.1/Spi-1 in myeloid cell-restricted expression of an interferon-inducible gene encoding the human high-affinity Fc gamma receptor. Mol Cell Biol (1994) 1.03
Recombinant tumor necrosis factors mediate platelet cytotoxicity to Schistosoma mansoni larvae. J Immunol (1988) 1.02
Production of antibodies against mouse immune T (type II) interferon and their neutralizing properties. J Gen Virol (1980) 1.01
Human U937 cell surface peptidase activities: characterization and degradative effect on tumor necrosis factor-alpha. Eur J Immunol (1992) 1.01
Hepatic phase of malaria is the target of cellular mechanisms induced by the previous and the subsequent stages. A crucial role for liver nonparenchymal cells. Immunol Lett (1990) 1.01
Tumor necrosis factor-alpha and IL-6 up-regulate IFN-gamma receptor gene expression in human monocytic THP-1 cells by transcriptional and post-transcriptional mechanisms. J Immunol (1992) 1.01
Treatment of multiple sclerosis patients with interferon-beta primes monocyte-derived macrophages for apoptotic cell death. J Leukoc Biol (2001) 0.99
Specific high-affinity receptors for interferon-gamma on mouse bone marrow-derived mast cells: inhibitory effect of interferon-gamma on mast cell precursors. Eur J Immunol (1990) 0.98
IFN-gamma is an essential cosignal for triggering IFN-beta 2/BSF-2/IL-6 gene expression in human monocytic cell lines. Ann N Y Acad Sci (1989) 0.98
Differential regulation of 4E-BP1 and 4E-BP2, two repressors of translation initiation, during human myeloid cell differentiation. J Immunol (1999) 0.98
Production of nitric oxide (NO) in human hydatidosis: relationship between nitrite production and interferon-gamma levels. Biochimie (1999) 0.96
Thioredoxin activation of iron regulatory proteins. Redox regulation of RNA binding after exposure to nitric oxide. J Biol Chem (1999) 0.96
Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. J Immunol (1986) 0.95
Importance, localization and functional properties of the cell-associated form of plasminogen activator in mouse peritoneal macrophages. Biochim Biophys Acta (1983) 0.95
Regulation of CD26/DPPIV gene expression by interferons and retinoic acid in tumor B cells. Oncogene (2000) 0.94
Kinetics of messenger accumulation coding for IFN gamma, related to modifications in the poly(A) RNA population of activated human lymphocytes. Nucleic Acids Res (1984) 0.94
Affinity chromatographic analysis of murine interferons induced by viruses and by T and B cell stimulants. Ann Immunol (Paris) (1977) 0.94
Influence of preincubation on the development of the inhibition of protein synthesis in extracts from interferon-treated mouse L cells. Action on tRNA. Virology (1978) 0.94
Induction of platelet cytotoxic functions by lymphokines: role of interferon-gamma. J Immunol (1987) 0.94
Canine visceral leishmaniasis: successful chemotherapy induces macrophage antileishmanial activity via the L-arginine nitric oxide pathway. Antimicrob Agents Chemother (1996) 0.93
Induction of p21Waf1/Cip1 by TNFalpha requires NF-kappaB activity and antagonizes apoptosis in Ewing tumor cells. Oncogene (2000) 0.93
Inhibitors of ADP-ribosylation impair inducible nitric oxide synthase gene transcription through inhibition of NF kappa B activation. Biochem Biophys Res Commun (1998) 0.93
Nicotinamide inhibits nitric oxide synthase mRNA induction in activated macrophages. Biochem J (1994) 0.92
Immune resistance to Trypanosoma cruzi: synergy of specific antibodies and recombinant interferon gamma in vivo. Ann Inst Pasteur Immunol (1987) 0.91
A single exogenous stimulus activates resident rat macrophages for nitric oxide production and tumor cytotoxicity. J Leukoc Biol (1993) 0.89
Converse modulation of IRP1 and IRP2 by immunological stimuli in murine RAW 264.7 macrophages. J Biol Chem (1998) 0.89
Relationship among circulating interferon, tumor necrosis factor-alpha, and interleukin-6 and serologic reaction against parasitic antigen in human hydatidosis. J Interferon Cytokine Res (1997) 0.89
Down-regulation of iron regulatory protein 1 gene expression by nitric oxide. Proc Natl Acad Sci U S A (2000) 0.89
Some properties of interferons induced by stimulants of T and B lymphocytes. Tex Rep Biol Med (1977) 0.89
Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages. Clin Exp Immunol (1999) 0.88
Synthesis of interferon in human lymphocytes stimulated "in vitro" by antilymphocytic serum. Rev Eur Etud Clin Biol (1972) 0.88
Control of Ia antigen expression on phagocytic cells of the thymic reticulum by interferon-gamma and prostaglandins. Eur J Immunol (1986) 0.88
Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. - Role of serum studied by a new spectrophotometric assay for plasminogen activators. Biochimie (1979) 0.88
Interaction of 14C-labelled amphotericin B derivatives with human erythrocytes: relationship between binding and induced K+ leak. Biochim Biophys Acta (1988) 0.87
Abnormal lymphokine production: a novel feature of the genetic disease Fanconi anemia. I. Involvement of interleukin-6. Hum Genet (1992) 0.87
Induction of interferon by mycoplasmas in mouse spleen cell cultures. J Interferon Res (1982) 0.87
IFN-mediated differential regulation of the expression of HLA-B7 and HLA-A3 class I genes. J Immunol (1989) 0.87
Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats. Parasitol Res (2001) 0.86
Antagonistic action of IFN-beta and IFN-gamma on high affinity Fc gamma receptor expression in healthy controls and multiple sclerosis patients. J Immunol (1998) 0.86
[Induction of human interferon by antilymphocyte serum]. C R Acad Sci Hebd Seances Acad Sci D (1970) 0.85
IFN-gamma reduces specific binding of tumor necrosis factor on murine macrophages. J Immunol (1991) 0.85
Human endothelial cells transfected by SV40 T antigens: characterization and potential use as a source of normal endothelial factors. Eur J Immunol (1992) 0.85
Modulation of iron regulatory protein functions. Further insights into the role of nitrogen- and oxygen-derived reactive species. J Biol Chem (1996) 0.85
Redox modulation of iron regulatory proteins by peroxynitrite. J Biol Chem (1997) 0.85
Immune interferon induced by phytohemagglutinin in nude mouse spleen cells. Infect Immun (1978) 0.85
Properties of mouse immune T-interferon (type II). Ann N Y Acad Sci (1980) 0.84
Levels of tumor necrosis factor alpha, gamma interferon, and interleukins 4,6, and 10 as determined in mice infected with virulent or attenuated strains of Trypanosoma cruzi. Parasitol Res (1999) 0.84
Inactivation of interleukin-6 in vitro by monoblastic U937 cell plasma membranes involves both protease and peptidyl-transferase activities. Eur J Biochem (1993) 0.84
Presence of a polynucleotide binding site on murine immune interferon (T-type). Biochem Biophys Res Commun (1978) 0.84
Human platelets possess receptors for a lymphokine: demonstration of high specific receptors for HuIFN-gamma. J Immunol (1987) 0.83
TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma: dependence on alpha 5 beta 1 and beta 2 integrins. Exp Cell Res (1996) 0.83
Divergent regulation of cell surface protease expression in HL-60 cells differentiated into macrophages with granulocyte macrophage colony stimulating factor or neutrophils with retinoic acid. Int Immunol (1993) 0.83
Effects of 2-deoxy-D-glucose on the glucose metabolism in Saccharomyces cerevisiae studied by multinuclear-NMR spectroscopy and biochemical methods. Biochimie (1992) 0.83
Analysis of the cell wall of five strains of Myocbacterium tuberculosis BCG and of an attenuated human strain, W 115. Infect Immun (1976) 0.83
Alterations in interferon-gamma and nitric oxide levels in human echinococcosis. Cell Mol Biol (Noisy-le-grand) (2006) 0.82
Acute and chronic experimental Trypanosoma cruzi infection in the rat. Response to systemic treatment with recombinant rat interferon-gamma. Microbiol Immunol (1995) 0.82
Pentoxifylline inhibits certain constitutive and tumor necrosis factor-alpha-induced activities of human normal dermal fibroblasts. J Invest Dermatol (1992) 0.82
TGF-beta-like activity produced during regression of exacerbations in multiple sclerosis. Acta Neurol Scand (1991) 0.82
Modulation of murine and human interferon-gamma receptor expression by their ligands or phorbol ester. Cytokine (1994) 0.82
Studies on purification of human gamma interferon: chromatographic behavior of accompanying IL2 and B-cell helper activity. J Interferon Res (1984) 0.82
Inhibition of gamma-glutamyl transpeptidase activity at the surface of human myeloid cells is correlated with macrophage maturation and transforming growth factor beta production. Cell Growth Differ (1995) 0.82
IFN-gamma and transforming growth factor-beta 1 differently regulate fibronectin and laminin receptors of human differentiating monocytic cells. J Immunol (1992) 0.82
Effects of hepatocellular iron imbalance on nitric oxide and reactive oxygen intermediates production in a model of sepsis. J Hepatol (2000) 0.82
Differential regulation of interleukin-6 receptors by interleukin-6 and interferons in multiple myeloma cell lines. Eur J Immunol (1994) 0.81